TransMedics Group, Inc. (NASDAQ:TMDX) is one of the Best Stocks to Buy for the Next 3 Months According to Hedge Funds. On August 4, TransMedics Group, Inc. (NASDAQ:TMDX) received conditional approval from the US FDA for its Investigational Device Exemption, allowing the company to start its Next-Generation OCS ENHANCE Heart trial. The trial has two parts, where the first part focuses on supporting prolonged heart perfusion using the OCS Heart System. Whereas the second part aims to prove that OCS Heart pe ...